Noriyuki Maeda

814 total citations
20 papers, 674 citations indexed

About

Noriyuki Maeda is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Noriyuki Maeda has authored 20 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Biomaterials and 6 papers in Biomedical Engineering. Recurrent topics in Noriyuki Maeda's work include Nanoparticle-Based Drug Delivery (12 papers), RNA Interference and Gene Delivery (6 papers) and Nanoplatforms for cancer theranostics (6 papers). Noriyuki Maeda is often cited by papers focused on Nanoparticle-Based Drug Delivery (12 papers), RNA Interference and Gene Delivery (6 papers) and Nanoplatforms for cancer theranostics (6 papers). Noriyuki Maeda collaborates with scholars based in Japan, United States and Australia. Noriyuki Maeda's co-authors include Naoto Oku, Tomohiro Asai, Yukihiro Namba, Yoshito Takeuchi, Yasufumi Katanasaka, Miki Takada, Kosuke Shimizu, Yasuyuki Sadzuka, Hiroyuki Koide and Takehisa Dewa and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and International Journal of Cancer.

In The Last Decade

Noriyuki Maeda

20 papers receiving 667 citations

Peers

Noriyuki Maeda
Xupeng Mu China
Prajna Mishra India
Minglu Zhou China
Iqbal Massodi United States
Qinglian Wen China
Meghna Mehta United States
Qiaoya Lin China
Pengfei Zhao China
Suo-Qin Tang China
Xupeng Mu China
Noriyuki Maeda
Citations per year, relative to Noriyuki Maeda Noriyuki Maeda (= 1×) peers Xupeng Mu

Countries citing papers authored by Noriyuki Maeda

Since Specialization
Citations

This map shows the geographic impact of Noriyuki Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriyuki Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriyuki Maeda more than expected).

Fields of papers citing papers by Noriyuki Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriyuki Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriyuki Maeda. The network helps show where Noriyuki Maeda may publish in the future.

Co-authorship network of co-authors of Noriyuki Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Noriyuki Maeda. A scholar is included among the top collaborators of Noriyuki Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriyuki Maeda. Noriyuki Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ando, Hidenori, Amr S. Abu Lila, Noriyuki Maeda, et al.. (2021). I.p.-injected cationic liposomes are retained and accumulate in peritoneally disseminated tumors. Journal of Controlled Release. 341. 524–532. 12 indexed citations
3.
Koide, Hiroyuki, et al.. (2020). Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery. International Journal of Pharmaceutics. 585. 119479–119479. 35 indexed citations
4.
Maeda, Noriyuki, et al.. (2016). Advanced lipid technology. Journal of Liposome Research. 27(3). 221–227. 5 indexed citations
5.
Okamoto, Ayaka, Tomohiro Asai, Hidenori Ando, et al.. (2016). Enhanced Efficacy of Doxorubicin by microRNA-499-Mediated Improvement of Tumor Blood Flow. Journal of Clinical Medicine. 5(1). 10–10. 20 indexed citations
6.
Koide, Hiroyuki, Tomohiro Asai, Hiroki Kato, et al.. (2014). Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin. Nanomedicine Nanotechnology Biology and Medicine. 11(1). 185–194. 14 indexed citations
7.
Ando, Hidenori, Tomohiro Asai, Hiroyuki Koide, et al.. (2014). Advanced cancer therapy by integrative antitumor actions via systemic administration of miR-499. Journal of Controlled Release. 181. 32–39. 36 indexed citations
8.
Asai, Tomohiro, et al.. (2013). Enhanced Active Targeting via Cooperative Binding of Ligands on Liposomes to Target Receptors. PLoS ONE. 8(6). e67550–e67550. 21 indexed citations
9.
10.
Asai, Tomohiro, Eriya Kenjo, Hiroyuki Koide, et al.. (2011). Dicetyl Phosphate-Tetraethylenepentamine-Based Liposomes for Systemic siRNA Delivery. Bioconjugate Chemistry. 22(3). 429–435. 50 indexed citations
11.
Katanasaka, Yasufumi, Takayuki Ishii, Tomohiro Asai, et al.. (2010). Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78. International Journal of Cancer. 127(11). 2685–2698. 85 indexed citations
12.
Asai, Tomohiro, et al.. (2009). A novel DDS strategy, “dual-targeting”, and its application for antineovascular therapy. Cancer Letters. 287(2). 165–171. 45 indexed citations
13.
Asai, Tomohiro, Noriyuki Maeda, Kentaro Hatanaka, et al.. (2008). Antineovascular therapy with angiogenic vessel‐targeted polyethyleneglycol‐shielded liposomal DPP–CNDAC. Cancer Science. 99(5). 1029–1033. 18 indexed citations
14.
Katanasaka, Yasufumi, et al.. (2008). Effective delivery of an angiogenesis inhibitor by neovessel-targeted liposomes. International Journal of Pharmaceutics. 360(1-2). 219–224. 33 indexed citations
15.
Katanasaka, Yasufumi, Tomohiro Asai, Kosuke Shimizu, et al.. (2008). Antiangiogenic cancer therapy using tumor vasculature-targeted liposomes encapsulating 3-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-1,3-dihydro-indol-2-one, SU5416. Cancer Letters. 270(2). 260–268. 32 indexed citations
16.
Maeda, Noriyuki, Kosuke Shimizu, Tomohiro Asai, et al.. (2006). Enhancement of Anticancer Activity in Antineovascular Therapy Is Based on the Intratumoral Distribution of the Active Targeting Carrier for Anticancer Drugs. Biological and Pharmaceutical Bulletin. 29(9). 1936–1940. 30 indexed citations
17.
Ichikawa, Kanae, Tomoya Hikita, Noriyuki Maeda, et al.. (2005). Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1669(1). 69–74. 61 indexed citations
18.
Maeda, Noriyuki, Yoshito Takeuchi, Miki Takada, Yukihiro Namba, & Naoto Oku. (2004). Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugate. Bioorganic & Medicinal Chemistry Letters. 14(4). 1015–1017. 20 indexed citations
19.
Maeda, Noriyuki, Yoshito Takeuchi, Miki Takada, et al.. (2004). Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome. Journal of Controlled Release. 100(1). 41–52. 104 indexed citations
20.
Ichikawa, Kanae, Tomoya Hikita, Noriyuki Maeda, et al.. (2004). PEGylation of Liposome Decreases the Susceptibility of Liposomal Drug in Cancer Photodynamic Therapy. Biological and Pharmaceutical Bulletin. 27(3). 443–444. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xupeng Mu Breakdown of academic impact, for papers by Prajna Mishra Breakdown of academic impact, for papers by Minglu Zhou Breakdown of academic impact, for papers by Iqbal Massodi Breakdown of academic impact, for papers by Qinglian Wen Breakdown of academic impact, for papers by Meghna Mehta Breakdown of academic impact, for papers by Qiaoya Lin Breakdown of academic impact, for papers by Pengfei Zhao Breakdown of academic impact, for papers by Suo-Qin Tang
Rankless by CCL
2026